Home Based Parkinsonās Care
Empowering people with Parkinsonās through self-care pathways

rDesign and deliver care pathway information and support materials
.Undertake patient and staff evaluation
AEnrol 150 patients from Āé¶¹“«Ć½, West Devon and East Cornwall
~Utilise feedback and evaluation to improve care pathway
Each year there are millions of face-to-face hospital outpatient appointments that do not need to take place in a hospital, nor do they need to occur face to face. This model of care whereby patients visit their specialist clinician for a time-locked review, regardless of need, is unsustainable and outdated for a Parkinsonās Service.
Current guidelines suggest people with Parkinsonās should receive specialist reviews at least every six months with a consultant or community Parkinsonās disease nurse specialist (PDNS), whatever the stage of their condition.
However, an audit conducted by the research team found that 46% of people experience consultant appointment delays of more than six months. 60% have not seen a community nurse within the last year.
In fact, some regions in the UK donāt have a specialist Parkinsonās service and 50% of vacant PDNS posts are due to long-term sick leave or resignation.
In the South West, we are working to empower and support people with Parkinsonās to play a more active role in their healthcare, from home. Moving away from traditional paternalistic healthcare, this approach moves to participatory healthcare.
"We are delighted to be shortlisted for a prestigious BMJ Award, which allows us to share our positive experience of a unique care pathway for Parkinsonās with patient needs at its centre. More technologies will become available in the future, offering huge potential for quality of life gains for people living with Parkinsonās. We have taken the first few steps towards this future. We want to inspire other services to share our journey, whilst at the same time celebrating the energy, support and efforts of our team and Parkinsonās community who are leading the way." Dr Camille Carroll
Developed by the Global Kinetics Corporation, the PKGĀ® monitors movement symptoms of Parkinsonās and processes them through a proprietary algorithm. Supplemented by a questionnaire that asks patients to detail non-motor symptoms such as changes in mood, patients wear the PKGĀ® over a six-day period during every day activities that enables them and their care team to identify and implement any required changes to therapy.
It provides the clinical team with detailed data regarding symptoms such as speed of movement, tremor and activity levels to support clinical decision making.
The project will also embed an app and web portal ā NMS Assist ā within the service that will allow the person with Parkinsonās and their care partner to record, monitor and report non-motor symptoms to the team.
The specialist Parkinsonās team then work remotely, ensuring that help ā including calls or clinic appointments ā can be offered when it is needed.
āThe UK prevalence of Parkinsonās disease will increase by a fifth by 2025, so the challenges associated with providing a timely and patient-centred service will also be much higher. We want to help people with Parkinsonās to live the best lives they can for as long as they can, and this project aims to empower patients to take control of their own condition.ā
Dr Camille Carroll, Associate Professor and Honorary Consultant Neurologist
The goal is to empower people with Parkinsonās.
The research teamwork extensively with people with Parkinsonās, their families and healthcare teams in the development of new care pathways to ensures that care delivery meets the needs and expectations of people living with Parkinsonās.
The service is also delivering an education package, providing information on how to ensure the service works best for patients, as well as providing people with the knowledge they need to manage their Parkinsonās symptoms better themselves and ālive wellā with Parkinsonās.
This works towards reducing the burden of attending hospital clinics and ensure appropriate and timely contacts to health services that aims to improve the quality of life for people with Parkinsonās and their care partners.
In turn, it allows a resilient and sustainable health service for a disease that is increasing in prevalence and complexity, enabling a service that works better for healthcare staff.
To collaborate with the Applied Parkinson's Research Group, please contact us via AppliedParkinsons@plymouth.ac.uk
The Applied Parkinsonās Research Group, led by Dr Camille Carroll, focuses on clinical trials of neuroprotective interventions in Parkinsonās, digital innovation for care and research, and genetic aspects of Parkinsonās.